A traditional Chinese medicine composition for secondary prevention after PCI of acute coronary syndrome
A technology for coronary syndrome and secondary prevention, applied in the field of traditional Chinese medicine, to achieve the effect of reducing rehospitalization rate, improving electrocardiogram, and dilating coronary arteries
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0043] Embodiment 1 Chinese medicine composition (one)
[0044] The raw materials are obtained according to the following proportions by weight: 5 parts of Xianlingpi, 3 parts of Taizishen, 0.8 parts of leeches, 5 parts of Salvia miltiorrhiza, and 2 parts of Yinhua.
Embodiment 2
[0045] Embodiment 2 Chinese medicine composition (two)
[0046] The raw materials are obtained according to the following proportions by weight: 15 parts of Xianlingpi, 13 parts of Taizishen, 1.8 parts of leeches, 15 parts of Salvia miltiorrhiza, and 6 parts of Yinhua.
Embodiment 3
[0047] Embodiment 3 Chinese medicine composition (three)
[0048] The raw materials are obtained according to the following proportions by weight: 5 parts of Xianlingpi, 13 parts of Taizishen, 0.8 parts of leeches, 15 parts of Salvia miltiorrhiza, and 2 parts of Yinhua.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com